Developing new treatments for Alzheimer's Disease through medicinal chemistry
MCSP - EXPLORATORY CHEMISTRY (EC)
['FUNDING_OTHER'] · ALBANY MOLECULAR RESEARCH, INC. · NIH-11062338
This study is exploring new ways to create medications for Alzheimer's Disease that could help patients by targeting the specific processes involved in the condition.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ALBANY MOLECULAR RESEARCH, INC. (nih funded) |
| Locations | 1 site (ALBANY, UNITED STATES) |
| Trial ID | NIH-11062338 on ClinicalTrials.gov |
What this research studies
This research focuses on the early stages of drug development for Alzheimer's Disease, utilizing advanced medicinal chemistry techniques. The project aims to identify and design new compounds that can effectively target the biological processes involved in Alzheimer's. By employing structure-activity relationship (SAR) analysis and in vitro testing for absorption, distribution, metabolism, excretion, and toxicity (ADMET), the research seeks to discover novel therapeutic options. Patients may benefit from potential new treatments that arise from this innovative approach to drug discovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's Disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for Alzheimer's Disease, improving patient outcomes.
How similar studies have performed: Previous research in medicinal chemistry has shown promise in developing effective treatments for neurodegenerative diseases, indicating a potential for success in this area.
Where this research is happening
ALBANY, UNITED STATES
- ALBANY MOLECULAR RESEARCH, INC. — ALBANY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BARNES, KEITH — ALBANY MOLECULAR RESEARCH, INC.
- Study coordinator: BARNES, KEITH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease